Shoppers Drug Mart Corp (SC.TO)

PAST TOP PICK
(A Top Pick Sept 17/08. Down 17.27%.) Continues to operate very well. This is a stock that everyone should have in their portfolio. Still a Buy.
HOLD
(Market Call Minute.) A little expensive. There is some uncertainty as to what is going to be happening with their relationship with the Ontario government regarding prescription drugs.
SELL
Is front a center in drug re-pricing. Province of Ontario is going to chip away at the margins. However is a good company with a strong balance sheet in a premier positioning the market place.
COMMENT
(Market Call Minute.) For people who want to dividend it could be worthwhile but not his kind of company.
DON'T BUY
This will continue its downtrend. Sales per square foot and same store sales are slowing a little. (Front end is doing better than the pharmacy.) Ontario government announced July 10 a major review of reimbursement plan for prescriptions and he expects significant downward pressure. Look to $40 for an entry point.
BUY
Numbers were terrific. Another solid quarter and continuing their 15% year-over-year growth, quarter after quarter. Conference call talked about pending changes by the Ontario government in their drug formula and what they are willing to pay on prescriptions. This has worried investors and it was oversold.
DON'T BUY
Excellent franchise but as a stock pick he would probably avoid it at this time. They matched the street estimates but the street has been lowering their estimates for next quarter's earnings, which is not a good sign. Consider Canadian Tire (CTC.A-T), which ranks well in his model.
COMMENT
Came out with earnings last week, which were not too bad. Front store sales were up 5.5%-6%, which looked pretty good. Issued a warning on Ontario drug reforms, which potentially could put pressure on margins on pharmaceutical sales. This is put pressure on the stock. Fairly high PE multiple of 16.
TOP PICK
Reported earnings, which he didn't think were so bad but the street hammer them because their growth forecasts were not very exciting. Very strong management team. Stock has been oversold.
PAST TOP PICK
(A Top Pick Jan 27/09. Up 7.1%.) 4.8% bond. Needed to raise some cash so he just sold this.
TOP PICK
Recession resistant but still has growth; a good combination in what she thinks will be a very difficult environment. Have a lot of ways to grow, square footage, private label, acquisition etc. Trading at a low multiple. Dividend yield in the 2% area but with a recent record of increasing it. Great balance sheet.
BUY
Didn't come down as hard as a lot of stocks, which probably speaks to its more defensive nature. Great retailer and has great growth. Trading at 15X earnings.
COMMENT
(Market Call Minute.) This is okay and it is doing all right and thinks it will do better over time.
TOP PICK
Defensive growth. Recently reported a good quarter. Continued to grow right through the recession. Still have plans to add about 10% square footage in their stores. Expecting 12% to 15% earnings growth.
TOP PICK
Market leader. Very strong management team. Recurring revenue model is very impressive. Front of the store is very well managed and focuses on health, beauty and convenience items. Have a strong track record of generating same-store sales growth. Higher loyalty in their customer base.
Showing 181 to 195 of 452 entries